Exhibit 99.1
Farmer Bros. Co. Reports Fiscal First Quarter 2022 Financial Results
NORTHLAKE, Texas, November 4, 2021 (GLOBE NEWSWIRE) - Farmer Bros. Co. (NASDAQ: FARM) (the “Company”) today reported financial results for its first fiscal quarter ended September 30, 2021.
First Quarter Fiscal 2022 Highlights:
•Net sales were $108.4 million, an increase of $11.1 million, or 11.4%, from the prior year period due to continued improvement in the direct-store-delivery ("DSD") channel compared to the prior year period
•Gross margin increased to 29.0% from 23.0% in the prior year period
•Net loss was $2.4 million compared to a net loss of $6.3 million in the prior year period
•Adjusted EBITDA was $3.5 million compared to $5.7 million in the prior year period*
•As of September 30, 2021, total debt outstanding was $89.0 million and cash and cash equivalents was $6.0 million
(*Adjusted EBITDA, a non-GAAP financial measure, is reconciled to its corresponding GAAP measure at the end of this press release.)
Deverl Maserang, Chief Executive Officer, commented, “We’re pleased to see the efficiencies that we’ve built into the business over the past twelve months continue to materialize, and we’re encouraged by the continued sequential improvement in sales trends. These factors are resulting in continued gross margin expansion and these benefits are beginning to flow through our improved operating cost structure. We experienced our highest DSD volume during the quarter since the onset of COVID, and our DSD sales volumes have continued to trend favorably in recent weeks. As sales continue to rebound, we’ve been ramping up our inventory, adding roasting capacity, and continuing our optimization efforts across our distribution and production network. While there continue to be lingering challenges associated with the pandemic, we’re excited to see how the business responds as we enter our busy season and look to the balance of the year.”
First Quarter Fiscal 2022 Results:
Selected Financial Data
The selected financial data presented below under the captions “Income statement data,” “Operating data” and “Other data” summarizes certain performance measures for the three months ended September 30, 2021 and 2020 (unaudited).
| Three Months Ended September 30, | ||||||||||||||
| 2021 | 2020 | |||||||||||||
| (In thousands, except per share data) | ||||||||||||||
| Income statement data: | ||||||||||||||
| Net sales | $ | 108,362 | $ | 97,270 | ||||||||||
| Gross margin | 29.0 | % | 23.0 | % | ||||||||||
| Loss from operations | $ | (1,780) | $ | (11,443) | ||||||||||
| Net loss | $ | (2,424) | $ | (6,270) | ||||||||||
| Net loss available to common stockholders per common share—diluted | $ | (0.14) | $ | (0.37) | ||||||||||
| Operating data: | ||||||||||||||
| Total Green Coffee pounds sold | ||||||||||||||
| Sold through DSD and Other | 6,164 | 4,773 | ||||||||||||
| Sold through Direct Ship | 13,712 | 16,160 | ||||||||||||
| EBITDA (1) | $ | 6,089 | $ | 2,906 | ||||||||||
| EBITDA Margin (1) | 5.6 | % | 3.0 | % | ||||||||||
| Adjusted EBITDA (1)(2) | $ | 3,489 | $ | 5,693 | ||||||||||
| Adjusted EBITDA Margin (1) | 3.2 | % | 5.9 | % | ||||||||||
| Other data: | ||||||||||||||
| Capital expenditures related to maintenance | $ | 2,243 | $ | 1,595 | ||||||||||
| Total capital expenditures | $ | 2,542 | $ | 4,366 | ||||||||||
| Depreciation and amortization expense | $ | 6,279 | $ | 7,041 | ||||||||||
(1) EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures; a reconciliation of these non-GAAP measures to their corresponding GAAP measures is included at the end of this press release.
(2) Adjusted EBITDA for the three months ended September 30, 2020 includes $7.2 million of higher amortized gains resulting from the curtailment of the postretirement medical plan in March 2020, which is further described in our consolidated financial statements in the 2021 Form 10-K.
Net sales in the first quarter of fiscal 2022 were $108.4 million, an increase of $11.1 million, or 11.4%, from the prior year period. The increase in net sales was driven primarily by continued recovery from the COVID-19 pandemic as local governments across the country eased restrictions and vaccines were distributed and rolled out successfully. During the quarter ended September 30, 2021, our average weekly DSD sales were down 25% compared to pre-COVID levels, which represents continued improvement from the quarter ended June 30, 2021 and quarter ended September 30, 2020 when sales were down 27% and 41%, respectively. Although we experienced improvement in several markets during the first fiscal quarter, the recovery in certain regions and markets was negatively impacted by the recent increase in COVID-19 cases which caused certain government restrictions to be reimplemented.
Our direct ship channel sales declined 5.7% during the three months ended September 30, 2021 compared to the prior year period. This was due to accounts we decided to exit during fiscal 2021 because they resulted in lower or negative profit due to the impacts from COVID-19 on their business. These declines were partially offset by the recovery from the COVID-19 impact of some of our other direct ship customers.
Gross profit in the first quarter of fiscal 2022 was $31.5 million, an increase of $9.1 million, or 40.3% from the prior year gross profit of $22.4 million, and gross margin increased 6.0% to 29.0% compared to 23.0% a year ago. This improvement was mostly due to the effect of the continued recovery from COVID-19 on our DSD channel sales since our DSD channel has higher margins. The increase was also attributable to a decline in our unfavorable production variances and inventory scrap write-downs due to the closure of our aged Houston, Texas plant during fiscal 2021.
Operating expenses in the first quarter of fiscal 2022 decreased $0.6 million, or 1.9%, to $33.2 million, from $33.9 million in the prior year period, and decreased as a percentage of net sales to 30.7% compared to 34.8% in the prior year period. The decrease in operating expenses was driven by a $5.2 million increase in net gains from the sales of assets primarily due to the sale of two branch properties during the quarter ended September 30, 2021. This decline was largely offset by a $2.5 million increase in selling expenses and a $2.1 million increase in general and administrative expenses. The increase in selling expenses was primarily due to variable costs, including payroll, associated with the higher sales volumes, as well as operating costs associated with our new distribution center in Rialto, California. The increase in general and administrative expenses was primarily due to payroll and third party costs related to several supply chain optimization initiatives. The increase in payroll in both selling and general and administrative expenses was predominately due to the return of the 15% temporary decline in base salaries and of the 401(k) cash match suspension that were both cost saving actions implemented in fiscal 2020 due to the COVID-19 pandemic.
Interest expense in the first quarter of fiscal 2022 decreased $0.2 million to $3.0 million from $3.2 million in the prior year period. The decrease in interest expense was principally due to the lower interest rate on our Credit Facilities, and fewer losses on our interest rate swap.
Other, net in the three months ended September 30, 2021 decreased by $6.1 million to income of $2.4 million compared to income of $8.6 million in the prior year period. The decrease was primarily a result of lower amortized gains on our terminated postretirement medical benefit plan, partially offset by higher mark-to-market net gains on coffee-related derivative instruments not designated as accounting hedges.
As a result of the foregoing factors, net loss was $2.4 million in the first quarter of fiscal 2022 as compared to a net loss of $6.3 million in the prior year period.
Our capital expenditures for the three months ended September 30, 2021 were $2.5 million, a decline of $1.9 million compared to the prior year period. This was due to lower investment spending of $2.5 million for several strategic initiatives completed during fiscal 2021, partially offset by higher maintenance capital spend of $0.6 million compared to the prior year period. The higher maintenance capital was due to coffee brewing equipment purchased for our DSD customers as volumes have improved. Several key initiatives, including a focus on refurbished coffee brewing equipment to drive cost savings, have helped reduce our purchases as DSD sales volumes return.
As of September 30, 2021, the outstanding principal on our Revolver and Term Loan Credit Facilities was $89.0 million, a decrease of $2.0 million since June 30, 2021. Our cash balance decreased by $4.3 million, from $10.3 million as of June 30, 2021, to $6.0 million as of September 30, 2021. These changes were due to higher inventory, as we increased purchases for our peak season during our second fiscal quarter, and payment of our fiscal 2021 employee incentive program. These uses of cash were partially offset by cash proceeds from the sale of two branch properties during the current quarter.
Non-GAAP Financial Measures:
EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP (U.S. generally accepted accounting principles) financial measures within the meaning of the rules of the Securities and Exchange Commission (“SEC”). See the Non-GAAP Financial Measures section on why the Company believes these supplemental measures are useful, reconciliations to the most directly comparable GAAP measure, and the limitations on the use of these supplemental measures.
Adjusted EBITDA was $3.5 million in the first quarter of fiscal 2022, as compared to $5.7 million in the prior year period, and Adjusted EBITDA Margin was 3.2% in the first quarter of fiscal 2022, as compared to 5.9% in the prior year period.
About Farmer Bros. Co.
Founded in 1912, Farmer Bros. Co. is a national coffee roaster, wholesaler and distributor of coffee, tea and culinary products. The Company’s product lines include organic, Direct Trade and sustainably-produced coffee. With a robust line of coffee, hot and iced teas, cappuccino mixes, spices, and baking/biscuit mixes, the Company delivers extensive beverage planning services and culinary products to its U.S. based customers. The Company serves a wide variety of customers, from small independent restaurants and foodservice operators to large institutional buyers like restaurant, department and convenience store chains, hotels, casinos, healthcare facilities, and gourmet coffee houses, as well as grocery chains with private brand coffee and consumer branded coffee and tea products, and foodservice distributors.
Headquartered in Northlake, Texas, Farmer Bros. Co. generated net sales of $397.8 million in fiscal 2021. The Company’s primary brands include Farmer Brothers®, Artisan Collection by Farmer Brothers™, Superior®, Metropolitan™, China Mist® and Boyds®.
Investor Conference Call
Deverl Maserang, Chief Executive Officer, and Scott Drake, Chief Financial Officer, will host an audio-only investor conference call today, November 4, 2021, at 5:00 p.m. Eastern time (4:00 p.m. Central time) to review the Company’s financial results for the first quarter ended September 30, 2021. The Company’s earnings press release will be available on the Company’s website at www.farmerbros.com under “Investor Relations.”
The call will be open to all interested investors through a live audio web broadcast via the Internet at https://edge.media-server.com/mmc/p/fjhai8vo and at the Company’s website www.farmerbros.com under “Investor Relations.” The call also will be available to investors and analysts by dialing Toll Free: (844) 423-9890. The passcode/ID is 8071699.
The audio-only webcast will be archived for at least 30 days on the Investor Relations section of the Farmer Bros. Co. website, and will be available approximately two hours after the end of the live webcast.
Forward-Looking Statements
This Quarterly Report on Form 10-Q and other documents we file with the Securities and Exchange Commission (“SEC”) contain forward-looking statements that are based on current expectations, estimates, forecasts and projections about us, our future performance, our financial condition, our products, our business strategy, our beliefs and our management’s assumptions. In addition, we, or others on our behalf, may make forward-looking statements in press releases or written statements, or in our communications and discussions with investors and analysts in the normal course of business through meetings, webcasts, phone calls and conference calls. These forward-looking statements can be identified by the use of words like “anticipates,” “estimates,” “projects,” “expects,” “plans,” “believes,” “intends,” “will,” “could,” “may,” “assumes” and other words of similar meaning. These statements are based on management’s beliefs, assumptions, estimates and observations of future events based on information available to our management at the time the statements are made and include any statements that do not relate to any historical or current fact. These statements are not guarantees of future performance and they involve certain risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may differ materially from what is expressed, implied or forecast by our forward-looking statements due in part to the risks, uncertainties and assumptions set forth in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2021 filed with the SEC on September 9, 2021 (the “2021 Form 10-K”) and Part II, Item 1A of this Quarterly Report on Form 10-Q, as well as those discussed elsewhere in this report and other factors described from time to time in our filings with the SEC.
Factors that could cause actual results to differ materially from those in forward-looking statements include, but are not limited to, duration of the disruption to our business and customers from the COVID-19 pandemic and severe winter weather,
levels of consumer confidence in national and local economic business conditions, the duration and magnitude of the pandemic’s impact on unemployment rates, the success of our strategy to recover from the effects of the pandemic, the success of our turnaround strategy, the execution of our five strategic initiatives, the impact of capital improvement projects, the adequacy and availability of capital resources to fund our existing and planned business operations and our capital expenditure requirements, the relative effectiveness of compensation-based employee incentives in causing improvements in our performance, the capacity to meet the demands of our large national account customers, the extent of execution of plans for the growth of our business and achievement of financial metrics related to those plans, our success in retaining and/or attracting qualified employees, our success in adapting to technology and new commerce channels, the effect of the capital markets as well as other external factors on stockholder value, fluctuations in availability and cost of green coffee, competition, organizational changes, the effectiveness of our hedging strategies in reducing price and interest rate risk, changes in consumer preferences, our ability to provide sustainability in ways that do not materially impair profitability, changes in the strength of the economy, business conditions in the coffee industry and food industry in general, our continued success in attracting new customers, variances from budgeted sales mix and growth rates, weather and special or unusual events, as well as other risks described in this Quarterly Report on Form 10-Q and other factors described from time to time in our filings with the SEC.
Given these risks and uncertainties, you should not rely on forward-looking statements as a prediction of actual results. Any or all of the forward-looking statements contained in this Quarterly Report on Form 10-Q and any other public statement made by us, including by our management, may turn out to be incorrect. We are including this cautionary note to make applicable and take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise, except as required under federal securities laws and the rules and regulations of the SEC.
FARMER BROS. CO.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except share and per share data)
| Three Months Ended September 30, | ||||||||||||||
| 2021 | 2020 | |||||||||||||
| Net sales | $ | 108,362 | $ | 97,270 | ||||||||||
| Cost of goods sold | 76,908 | 74,851 | ||||||||||||
| Gross profit | 31,454 | 22,419 | ||||||||||||
| Selling expenses | 26,009 | 23,498 | ||||||||||||
| General and administrative expenses | 11,807 | 9,746 | ||||||||||||
| Net (gains) losses from sales of assets | (4,582) | 618 | ||||||||||||
| Operating expenses | 33,234 | 33,862 | ||||||||||||
| Loss income from operations | (1,780) | (11,443) | ||||||||||||
| Other (expense) income: | ||||||||||||||
| Interest expense | (3,026) | (3,244) | ||||||||||||
| Other, net | 2,444 | 8,559 | ||||||||||||
| Total other (expense) income | (582) | 5,315 | ||||||||||||
| Loss before taxes | (2,362) | (6,128) | ||||||||||||
| Income tax expense | 62 | 142 | ||||||||||||
| Net loss | (2,424) | $ | (6,270) | |||||||||||
| Less: Cumulative preferred dividends, undeclared and unpaid | 147 | 142 | ||||||||||||
| Net loss available to common stockholders | $ | (2,571) | $ | (6,412) | ||||||||||
| Net loss available to common stockholders per common share—basic | $ | (0.14) | $ | (0.37) | ||||||||||
| Net loss available to common stockholders per common share—diluted | $ | (0.14) | $ | (0.37) | ||||||||||
Weighted average common shares outstanding—basic | 17,969,694 | 17,420,442 | ||||||||||||
Weighted average common shares outstanding—diluted | 17,969,694 | 17,420,442 | ||||||||||||
FARMER BROS. CO.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share and per share data)
| September 30, | June 30, | |||||||
| 2021 | 2021 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 6,014 | $ | 10,263 | ||||
| Restricted cash | 175 | 175 | ||||||
| Accounts receivable, net of allowance for doubtful accounts of $334 and $325, respectively | 43,377 | 40,321 | ||||||
| Inventories | 83,862 | 76,791 | ||||||
| Short-term derivative assets | 8,798 | 4,351 | ||||||
| Prepaid expenses | 6,024 | 5,594 | ||||||
| Assets held for sale | 90 | 1,591 | ||||||
| Total current assets | 148,340 | 139,086 | ||||||
| Property, plant and equipment, net | 146,703 | 150,091 | ||||||
| Intangible assets, net | 17,649 | 18,252 | ||||||
| Right-of-use operating lease assets | 29,133 | 26,254 | ||||||
| Other assets | 3,911 | 4,323 | ||||||
| Total assets | $ | 345,736 | $ | 338,006 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | 52,816 | 45,703 | ||||||
| Accrued payroll expenses | 10,749 | 15,345 | ||||||
| Operating leases liabilities - current | 6,908 | 6,262 | ||||||
| Term loan - current | 1,900 | 950 | ||||||
| Short-term derivative liabilities | 1,730 | 1,555 | ||||||
| Other current liabilities | 7,717 | 6,425 | ||||||
| Total current liabilities | 81,820 | 76,240 | ||||||
| Long-term borrowings under revolving credit facility | 41,500 | 43,500 | ||||||
| Term loan - noncurrent | 43,432 | 44,328 | ||||||
| Accrued pension liabilities | 39,179 | 39,229 | ||||||
| Accrued postretirement benefits | 958 | 960 | ||||||
| Accrued workers’ compensation liabilities | 3,649 | 3,649 | ||||||
| Operating lease liabilities - noncurrent | 22,455 | 20,049 | ||||||
| Other long-term liabilities | 4,710 | 5,092 | ||||||
| Total liabilities | $ | 237,703 | $ | 233,047 | ||||
| Commitments and contingencies | ||||||||
| Stockholders’ equity: | ||||||||
| Preferred stock, $1.00 par value, 500,000 shares authorized; Series A Convertible Participating Cumulative Perpetual Preferred Stock, 21,000 shares authorized; 14,700 shares issued and outstanding as of September 30, 2021 and June 30, 2021; liquidation preference of $16,899 and $16,752 as of September 30, 2021 and June 30, 2021, respectively | 15 | 15 | ||||||
| Common stock, $1.00 par value, 25,000,000 shares authorized; 17,998,797 and 17,852,793 shares issued and outstanding as of September 30, 2021 and June 30, 2021, respectively | 17,999 | 17,853 | ||||||
| Additional paid-in capital | 67,355 | 66,109 | ||||||
| Retained earnings | 63,740 | 66,311 | ||||||
| Accumulated other comprehensive loss | (41,076) | (45,329) | ||||||
| Total stockholders’ equity | $ | 108,033 | $ | 104,959 | ||||
| Total liabilities and stockholders’ equity | $ | 345,736 | $ | 338,006 | ||||
| FARMER BROS. CO. | |||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) | |||||||||||
| (In thousands) | |||||||||||
| Three Months Ended September 30, | |||||||||||
| 2021 | 2020 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net loss | $ | (2,424) | $ | (6,270) | |||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
| Depreciation and amortization | 6,279 | 7,041 | |||||||||
| Net (gains) losses from sales of assets | (4,582) | 618 | |||||||||
| Net (gains) losses on derivative instruments | (3,192) | 807 | |||||||||
| Other adjustments | 1,497 | 958 | |||||||||
| Change in operating assets and liabilities: | |||||||||||
| Accounts receivable | (3,160) | (1,046) | |||||||||
| Inventories | (7,753) | (4,321) | |||||||||
| Derivative assets (liabilities), net | 2,946 | (7,553) | |||||||||
| Other assets | (19) | 1,181 | |||||||||
| Accounts payable | 6,863 | 12,880 | |||||||||
| Accrued expenses and other | (3,190) | 4,690 | |||||||||
| Net cash (used in) provided by operating activities | $ | (6,735) | $ | 8,985 | |||||||
| Cash flows from investing activities: | |||||||||||
| Purchases of property, plant and equipment | (2,542) | (4,366) | |||||||||
| Proceeds from sales of property, plant and equipment | 7,297 | 226 | |||||||||
| Net cash provided (used) in investing activities | $ | 4,755 | $ | (4,140) | |||||||
| Cash flows from financing activities: | |||||||||||
| Proceeds from Credit Facilities | 2,000 | 3,000 | |||||||||
| Repayments on Credit Facilities | (4,000) | (55,200) | |||||||||
| Payments of finance lease obligations | (48) | (9) | |||||||||
| Payment of financing costs | (221) | (1,624) | |||||||||
| Net cash used in financing activities | (2,269) | $ | (53,833) | ||||||||
| Net decrease in cash and cash equivalents and restricted cash | (4,249) | $ | (48,988) | ||||||||
| Cash and cash equivalents and restricted cash at beginning of period | 10,438 | 60,013 | |||||||||
| Cash and cash equivalents and restricted cash at end of period | $ | 6,189 | $ | 11,025 | |||||||
Non-GAAP Financial Measures
In addition to net loss determined in accordance with U.S. generally accepted accounting principles (“GAAP”), we use the following non-GAAP financial measures in assessing our operating performance:
“EBITDA” is defined as net loss excluding the impact of:
•income taxes;
•interest expense; and
•depreciation and amortization expense.
“EBITDA Margin” is defined as EBITDA expressed as a percentage of net sales.
“Adjusted EBITDA” is defined as net loss excluding the impact of:
•income taxes;
•interest expense (benefit);
•(loss) income from short-term investments;
•depreciation and amortization expense;
•ESOP and share-based compensation expense;
•severance costs;
•non-recurring costs associated with the COVID-19 pandemic;
•net gains and losses from sales of assets;
•non-cash pension settlements and postretirement benefits curtailment; and
•acquisition, integration and strategic initiative costs.
“Adjusted EBITDA Margin” is defined as Adjusted EBITDA expressed as a percentage of net sales.
For purposes of calculating EBITDA and EBITDA Margin and Adjusted EBITDA and Adjusted EBITDA Margin, we have not adjusted for the impact of interest expense on our pension and postretirement benefit plans.
We believe these non-GAAP financial measures provide a useful measure of the Company’s operating results, a meaningful comparison with historical results and with the results of other companies, and insight into the Company’s ongoing operating performance. Further, management utilizes these measures, in addition to GAAP measures, when evaluating and comparing the Company’s operating performance against internal financial forecasts and budgets.
We believe that EBITDA facilitates operating performance comparisons from period to period by isolating the effects of certain items that vary from period to period without any correlation to core operating performance or that vary widely among similar companies. These potential differences may be caused by variations in capital structures (affecting interest expense), tax positions (such as the impact on periods or companies of changes in effective tax rates or net operating losses) and the age and book depreciation of facilities and equipment (affecting relative depreciation expense). We also present EBITDA and EBITDA Margin because (i) we believe that these measures are frequently used by securities analysts, investors and other interested parties to evaluate companies in our industry, (ii) we believe that investors will find these measures useful in assessing our ability to service or incur indebtedness, and (iii) we use these measures internally as benchmarks to compare our performance to that of our competitors.
EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin, as defined by us, may not be comparable to similarly titled measures reported by other companies. We do not intend for non-GAAP financial measures to be considered in isolation or as a substitute for other measures prepared in accordance with GAAP.
Set forth below is a reconciliation of reported net loss to EBITDA (unaudited):
| Three Months Ended September 30, | ||||||||||||||
| (In thousands) | 2021 | 2020 | ||||||||||||
| Net loss, as reported | $ | (2,424) | $ | (6,270) | ||||||||||
| Income tax expense | 62 | 142 | ||||||||||||
| Interest expense(1) | 2,172 | 1,993 | ||||||||||||
| Depreciation and amortization expense | 6,279 | 7,041 | ||||||||||||
| EBITDA | $ | 6,089 | $ | 2,906 | ||||||||||
| EBITDA Margin | 5.6 | % | 3.0 | % | ||||||||||
____________
(1)Excludes interest expense related to pension plans and postretirement benefits plan.
Set forth below is a reconciliation of reported net loss to Adjusted EBITDA (unaudited):
| Three Months Ended September 30, | ||||||||||||||
| (In thousands) | 2021 | 2020 | ||||||||||||
| Net loss, as reported | $ | (2,424) | $ | (6,270) | ||||||||||
| Income tax expense | 62 | 142 | ||||||||||||
| Interest expense(1) | 2,172 | 1,993 | ||||||||||||
| Depreciation and amortization expense | 6,279 | 7,041 | ||||||||||||
| ESOP and share-based compensation expense | 1,392 | 1,155 | ||||||||||||
| Strategic initiatives | — | 341 | ||||||||||||
| Net (gains) losses from sales of other assets | (4,582) | 618 | ||||||||||||
| Non-recurring costs associated with the COVID-19 pandemic | — | 111 | ||||||||||||
| Severance | 590 | 562 | ||||||||||||
| Adjusted EBITDA (2) | 3,489 | $ | 5,693 | |||||||||||
| Adjusted EBITDA Margin | 3.2 | % | 5.9 | % | ||||||||||
________
(1) Excludes interest expense related to pension plans and postretirement benefit plans.
(2) Adjusted EBITDA for the three months ended September 30, 2020 includes $7.2 million of higher amortized gains resulting from the curtailment of the postretirement medical plan in March 2020, which is further described in our consolidated financial statements in the 2021 Form 10-K.
Contact:
Ellipsis
Jeff Majtyka & Kyle King
646-776-0886